A&M Capital takes majority stake in GBUK

GBUK Group is a specialist single-use medical devices provider.

  • A&M Capital Europe is acquiring GBUK from H2 Equity Partners 
  • With AMCE’s support, GBUK intends to pursue bolt-on acquisitions
  • GBUK will continue under the leadership of its existing management team

A&M Capital Europe has announced the acquisition of a majority stake in GBUK Group from H2 Equity Partners.

GBUK develops and distributes its own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The company is based in Selby in England.

With AMCE’s support, GBUK intends to pursue bolt-on acquisitions, focusing primarily on proprietary medical device specialists in the United Kingdom and broader European and North American markets, according to a press statement.

H2 Equity invested in GBUK in 2015.

A&M Capital Europe is a pan-European, London-headquartered, middle-market private equity firm with €650 million of assets under management. It is part of Alvarez & Marsal Capital, a multi-strategy private equity investment firm.

H2 focuses on mid-sized companies with an “attractive” long-term outlook. The firm has offices in Amsterdam and London.